Form 10-Q INTERCEPT PHARMACEUTICAL For: Jun 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Form 10-Q INTERCEPT PHARMACEUTICAL For: Jun 30

Intercept Pharm (ICPT) Posts Q2 Loss of 79c/Share; Issues Positive FLINT Data

August 11, 2014 4:16 PM EDT

Intercept Pharm (NASDAQ: ICPT) reported Q2 EPS of ($0.79), which may not compare with the analyst estimate of ($0.12). Revenue for the quarter came in at $405.4 million versus the consensus estimate of $400 million.

Included in net income for the second quarter of 2014 is a $55.8 million non-cash gain recorded for the revaluation of all outstanding warrants which were exercised in April 2014.

Cash Position

As of June 30, 2014, Intercept had cash, cash equivalents and investment securities available for sale of approximately $299.0 million. In April 2014, Intercept completed an underwritten public offering of 1,000,000 shares of common stock, of which... More